1. 452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control. (10th December 2020) Authors: Rossi, Matteo; Belnoue, Elodie; Carboni, Susanna; Berardino, Wilma Besson-Di; Riva, Erika; Santiago-Raber, Marie-Laure; Derouazi, Madiha Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control. (9th November 2020) Authors: Rossi, Matteo; Belnoue, Elodie; Carboni, Susanna; Berardino, Wilma Besson-Di; Riva, Erika; Santiago-Raber, Marie-Laure; Derouazi, Madiha Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗